Results 221 to 230 of about 147,672 (267)

Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging

open access: gold, 2019
Emanuele Naglieri   +5 more
openalex   +1 more source

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. [PDF]

open access: yesJ Clin Oncol
Barata P   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy